Zenith Healthcare Limited has issued a regulatory disclosure to BSE Ltd. regarding an upcoming Board of Directors meeting. The meeting is scheduled for Wednesday, October 28, 2026, and will be held at the company's Registered Office at 504, Iscon Elegance, Nr. Ananddham Jain Derasar, Prahladnagar Cross Road, S.G. Road, Ahmedabad – 380 015.
The primary agenda for the board meeting includes:
- Consideration and approval of the unaudited financial results of the Company for the quarter and half year ended on 30th September, 2026
- Any other matter with the permission of the Chair
The disclosure is made under Regulation 29 and other applicable regulations of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Additionally, the company confirms that the Trading Window for dealing in securities remains closed in terms of SEBI (Prohibition of Insider Trading) Regulations and the company's Code of Conduct for Prevention of Insider Trading. The trading window had been closed earlier and will remain closed until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026.
The document includes the company's operational addresses:
- Unit 1: 388/34, Changodar Industrial Estate, Sakrhej-Bavla Highway, Changodar, Ahmedabad - 382213 (Gujarat)
- Unit 2: Survey No. 1078, Bhat Chancharwadi Road, Bhat, Ahmedabad - 382210 (Gujarat)
- Godown: 56/B, Changodar Industrial Estate, Vibhag-1, Godown No.1, Sarkhej-Bavla Highway, Changodar, Ahmedabad - 382213 (Gujarat)